Neodyne Biosciences Reports Published Favorable Results of a...

... trial of the embrace device (REFINE) are scheduled to be presented at the American Society for Aesthetic Plastic Surgery Meeting, April 24- 29, in San Francisco. Neodyne's first product, embrace Advanced Scar Therapy, received 510(k) clearance from ...

http://ift.tt/1hRw8NT